ClinVar Miner

Submissions for variant NM_004646.4(NPHS1):c.3061dup (p.Asp1021fs)

dbSNP: rs34124941
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 3
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Counsyl RCV000670157 SCV000794981 likely pathogenic Finnish congenital nephrotic syndrome 2017-10-24 criteria provided, single submitter clinical testing
Baylor Genetics RCV000670157 SCV004191465 pathogenic Finnish congenital nephrotic syndrome 2023-03-23 criteria provided, single submitter clinical testing
Labcorp Genetics (formerly Invitae), Labcorp RCV003558504 SCV004297299 pathogenic not provided 2023-07-16 criteria provided, single submitter clinical testing This variant is present in population databases (rs34124941, gnomAD 0.0009%). This premature translational stop signal has been observed in individual(s) with nephrotic syndrome (PMID: 28117080). ClinVar contains an entry for this variant (Variation ID: 554509). For these reasons, this variant has been classified as Pathogenic. This sequence change creates a premature translational stop signal (p.Asp1021Glyfs*6) in the NPHS1 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in NPHS1 are known to be pathogenic (PMID: 11317351, 11854170, 12039988).

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.